140 related articles for article (PubMed ID: 34738049)
1. Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma.
Cavalieri S; Serafini MS; Carenzo A; Canevari S; Brakenhoff RH; Leemans CR; Nauta IH; Hoebers F; van den Hout MFCM; Scheckenbach K; Hoffmann TK; Ardighieri L; Poli T; Quattrone P; Locati LD; Licitra L; De Cecco L
JCO Precis Oncol; 2021; 5():. PubMed ID: 34738049
[TBL] [Abstract][Full Text] [Related]
2. How applicable is the TNM 8 staging for human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) to a UK population of 106 patients? : A cohort comparison of the TNM 7 and TNM8 staging systems for HPV positive oropharyngeal cancer in a UK population.
Bradish T; Fisher H; Paleri V; Robinson M; Meikle D; Kelly C; O'Hara J
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):755-761. PubMed ID: 32621245
[TBL] [Abstract][Full Text] [Related]
3. Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
De Felice F; Bird T; Michaelidou A; Thavaraj S; Odell E; Sandison A; Hall G; Morgan P; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Lei M; Guerrero Urbano T
Radiother Oncol; 2020 Apr; 145():146-153. PubMed ID: 31981964
[TBL] [Abstract][Full Text] [Related]
4. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
5. Patient Selection in Human Papillomavirus Related Oropharyngeal Cancer: The Added Value of Prognostic Models in the New TNM 8th Edition Era.
Deschuymer S; Dok R; Laenen A; Hauben E; Nuyts S
Front Oncol; 2018; 8():273. PubMed ID: 30083517
[No Abstract] [Full Text] [Related]
6. [Prognostic factors for overall survival in oropharyngeal carcinoma depending on HPV status].
Riders A; Oberste M; Abbaspour B; Beule A; Rudack C
HNO; 2022 Feb; 70(2):102-109. PubMed ID: 34170339
[TBL] [Abstract][Full Text] [Related]
7. Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual.
Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
Eur J Surg Oncol; 2019 Jun; 45(6):1046-1053. PubMed ID: 30857877
[TBL] [Abstract][Full Text] [Related]
8. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
12. Postoperative staging of the neck dissection using extracapsular spread and lymph node ratio as prognostic factors in HPV-negative head and neck squamous cell carcinoma patients.
Majercakova K; Valero C; López M; García J; Farré N; Quer M; León X
Oral Oncol; 2018 Feb; 77():37-42. PubMed ID: 29362124
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Nocon CC; Kuchta K; Bhayani MK
Head Neck; 2021 May; 43(5):1476-1486. PubMed ID: 33415799
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
[TBL] [Abstract][Full Text] [Related]
16. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
[TBL] [Abstract][Full Text] [Related]
17. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Snietura M; Brewczynski A; Kopec A; Rutkowski T
Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
[TBL] [Abstract][Full Text] [Related]
18. A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
Patel KB; Mroz EA; Faquin WC; Rocco JW
Oral Oncol; 2021 Sep; 120():105421. PubMed ID: 34198234
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region.
Ren J; Yang W; Su J; Ren X; Fazelzad R; Albert T; Habbous S; Goldstein DP; de Almeida JR; Hansen A; Jang R; Bratman SV; Hope A; Chen R; Wang J; Xu Y; Cheng D; Zhao Y; Xu W; Liu G
Int J Cancer; 2019 Sep; 145(6):1465-1474. PubMed ID: 30698281
[TBL] [Abstract][Full Text] [Related]
20. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
